Nutex Health Q3 revenue falls 18.7% to $217.6 million; net income and EPS decline
Nutex Health reported third-quarter 2026 results, with total revenue down 18.7% to $217.6 million from $267.8 million a year earlier. Net income attributable to the company fell to $40.2 million, or $5.71 per diluted share, from $55.4 million, or $7.76, in the same quarter of 2025. Both headline revenue and profit declined, and the company did not provide guidance in this filing.
Key points
- Q3 2026 total revenue was $217.6 million, down 18.7% from $267.8 million; same-hospital hospital division revenue fell 20.1%.
- Q3 2026 net income attributable to Nutex Health was $40.2 million, or $5.71 diluted EPS, versus $55.4 million, or $7.76, a year earlier.
- Nine-month net income attributable to Nutex Health rose to $152.9 million, or $21.50 diluted EPS, helped by a $52.3 million change in estimate tied to the HaloMD agreement amendment.
- The company will host a conference call on Friday, November 6, 2026 at 9:30 a.m. CT.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.